4D Molecular Therapeutics, Inc. (FDMT)
4D Molecular Therapeutics Market Cap : 589.68M for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 18, 2026 | 589.68M |
| November 17, 2026 | 608.28M |
| November 16, 2026 | 636.47M |
| November 13, 2026 | 689.46M |
| November 12, 2026 | 682.98M |
| November 11, 2026 | 732.30M |
| November 10, 2026 | 702.43M |
| November 09, 2026 | 689.07M |
| November 06, 2026 | 676.37M |
| November 05, 2026 | 621.16M |
| November 04, 2026 | 678.03M |
| November 03, 2026 | 659.81M |
| November 02, 2026 | 627.78M |
| October 30, 2026 | 657.05M |
| October 29, 2026 | 705.64M |
| October 28, 2026 | 713.92M |
| October 27, 2026 | 660.36M |
| October 26, 2026 | 609.01M |
| October 23, 2026 | 596.31M |
| October 22, 2026 | 654.29M |
| October 21, 2026 | 696.80M |
| October 20, 2026 | 723.30M |
| October 19, 2026 | 678.58M |
| October 16, 2026 | 670.30M |
| October 15, 2026 | 710.61M |
| Date | Value |
|---|---|
| October 14, 2026 | 673.61M |
| October 13, 2026 | 682.45M |
| October 12, 2026 | 717.78M |
| October 09, 2026 | 736.00M |
| October 08, 2026 | 701.22M |
| October 07, 2026 | 695.15M |
| October 06, 2026 | 693.49M |
| October 05, 2026 | 713.37M |
| October 02, 2026 | 754.78M |
| October 01, 2026 | 764.16M |
| September 30, 2026 | 790.11M |
| September 29, 2026 | 800.05M |
| September 28, 2026 | 803.92M |
| September 25, 2026 | 798.95M |
| September 24, 2026 | 812.20M |
| September 23, 2026 | 828.21M |
| September 22, 2026 | 876.80M |
| September 21, 2026 | 841.46M |
| September 18, 2026 | 840.36M |
| September 17, 2026 | 810.54M |
| September 16, 2026 | 759.75M |
| September 15, 2026 | 752.57M |
| September 14, 2026 | 759.75M |
| September 11, 2026 | 727.17M |
| September 10, 2026 | 744.84M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Agenus, Inc. | 289.34M |
| Amgen, Inc. | 240.10B |
| Anika Therapeutics, Inc. | 182.43M |
| BioCryst Pharmaceuticals, Inc. | 1.870B |
| Imunon, Inc. | 3.602M |
Market Cap Related Metrics
| PS Ratio | 7.301 |
| Price to Book Value | 1.745 |
| Price | 10.46 |
| Earnings Yield | -26.69% |